SOURCE: Market Pulse

June 06, 2005 08:30 ET

Market Pulse Breaking News Alert for Monday, June 6, 2005: BIPH - Biophan Issued New Patent for Solution to Enhance Image Quality of Magnetic Resonance Imaging - MRI - of Medical Devices!

NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Market Pulse.

ATLANTA, GA -- (MARKET WIRE) -- June 6, 2005 -- Market Pulse News Alert for this AM, Stocks to Watch are: Biophan Technologies, Inc. (OTC BB: BIPH), La Jolla Pharmaceutical Co. (NASDAQ: LJPC), Chinadotcom Corp. (NASDAQ: CHINA), and Able Energy Inc. (NASDAQ: ABLE).

Investors need to be watching Biophan Technologies, Inc. (OTC BB: BIPH) this AM! Biophan develops and markets cutting-edge technologies designed to make biomedical devices safe and compatible with the magnetic resonance imaging (MRI) environment. Biophan's technology is also being used to create MRI contrast agents, and has expanded to include other applications, such as drug delivery and power systems derived from body heat. Biophan has joint development arrangements with Boston Scientific and NASA's Ames Center for Nanotechnology. BIPH has had several excellent news announcements lately and one again after Friday's bell regarding its being granted a new U.S. patent! This could be great news for investors!

Biophan Technologies, Inc. (OTC BB: BIPH), a developer of next-generation medical technology, announced today that the U.S. Patent No. 6,902,290 has been granted to the Company. The patent teaches the placement of an electronic sensor within medical devices that can offset the image artifacts that interfere with the quality of MRI imaging.

The new patent supports Biophan's strategy of aggressive expansion of its intellectual property portfolio with proprietary solutions covering opportunities across several multi-billion-dollar segments of the healthcare and biomedical device marketplace.

The Company's intellectual property portfolio currently comprises 127 U.S. issued or pending patents and 46 international issued or pending patents, representing a commanding industry lead.

"This patent is part of our technology suite for making medical devices safe and compatible for operation with MRI imaging," said Michael Weiner, CEO of Biophan. "To the best of our knowledge, we hold directly or through exclusive licenses, the vast majority of the issued patents that address the safety and the image compatibility between MRI systems and implantable and interventional medical devices. This allows us to supply manufacturers with a toolkit of solutions to resolve the MRI-safety and image-quality problems inherent in many medical devices, both on the market and on the drawing boards."

Biophan's mission is to improve medical devices and offer them to strategic partners to impact their market share, producing revenue and profit for Biophan shareholders.

"This recently issued patent results from Biophan's conviction that solving the MRI safety problem alone is not sufficient," said Mr. Weiner. "The patent teaches modifying the circuitry of devices such as pacemakers to improve their compatibility with MRI. This is an extension to our technology suite, which includes an RF filter licensed from Johns Hopkins University, and anti-antenna geometry modifications that are placed in the wire lead connecting the implantable device to tissue for sensing or therapeutic function."

A growing body of published medical research is drawing attention to the need for improved safety and visualization of MRI imaging with these devices. Leading medical device makers, such as Medtronic Inc. and Guidant Corp. as well as the FDA, have all publicly expressed the need for technology solutions that will make the use of MRI both safe and effective for patients receiving these devices.

"Now that the critical need for making medical devices safe for use with MRI machines is gaining widespread recognition, Biophan is positioned to help device manufacturers design their devices to be safe and image compatible with MRI, and we can offer them a wide variety of solutions," said Mr. Weiner. "There is no longer any excuse for not making and certifying devices to be safe with MRI machines. It is important to bring an end to the many problems that have hampered recipients of these life enhancing medical devices from undergoing critical and beneficial MRI diagnostic procedures. We are pleased with the growing activity among device manufacturers interested in fixing the problem, and exploring the use of our patented solutions."

To view details of the newly issued patent, please visit http://www.biophan.com/newpatents/6901290.pdf.

About Biophan Technologies

Biophan develops and markets cutting-edge technologies designed to make biomedical devices safe and compatible with the magnetic resonance imaging (MRI) environment. The Company develops enabling technologies for implanted medical systems such as pacemakers and interventional surgical devices such as catheters, guidewires, stents, and other implants to allow them to be safely and effectively imaged under MRI. The technology is also being used to create MRI contrast agents, and has expanded to include other applications, such as drug delivery and power systems derived from body heat. Four Biophan technologies include advances in nanotechnology and thin film coatings. Committed to growth through innovation and developmental leadership, Biophan and its licensors now hold a total of 127 U.S. patents, licenses, or applications. This total includes 37 issued U.S. patents, 8 recently allowed applications that will issue as patents in the near future, and 82 pending applications at various stages of examination at the U.S. Patent and Trademark Office, plus international applications. The patents cover areas including nanotechnology (nanomagnetic particle coatings), radio frequency filters, polymer composites, thermoelectric materials for batteries generating power from body heat, and photonics. Biophan has joint development arrangements with Boston Scientific and NASA's Ames Center for Nanotechnology. Biophan's goal is to make all biomedical devices capable of safely and successfully working with MRI, and delivering other technologies which will improve quality of life. For more information, please visit www.biophan.com.

Stocks acting well as of late include: La Jolla Pharmaceutical Co. (NASDAQ: LJPC), Chinadotcom Corp. (NASDAQ: CHINA), and Able Energy Inc. (NASDAQ: ABLE).

Information contained herein is the opinion of Market-Pulse.com ("MP") and is intended to be used strictly for informational purposes. You should be aware that MP attempts to assure itself of the accuracy of the information contained in the analyses it publishes. In this regard, MP does, at times, rely on the accuracy of information supplied to it by the companies which are the subject of MP's analyses and/or parties related to those companies. MP also relies on the accuracy and integrity of information that is contained in company press releases and reports filed with the SEC. The companies mentioned in this publication have not approved the content or timing of the information being published unless otherwise noted.

MP, because it relies on information supplied by various third parties disclaims any responsibility for the accuracy of such information. Any investor considering making an investment in any security which has been the subject of a MP analysis or opinion should, before making any such investment, consult with his/her market professional and/or do his/her own independent research regarding the company which is the subject of an MP opinion, recommendation or analysis. Information regarding companies which MP has opined upon is normally available from many sources including the subject company's filings with the SEC and various press releases issued by the company.

You should be aware that MP is often compensated for issuing analyses, recommendations or opinions concerning particular companies. Its opinion is therefore not unbiased and you should consider this factor when evaluating MP's statements regarding a company. MP has been compensated one hundred fifty thousand dollars from Biophan Technologies, Inc. MP's officers and directors reserve the right to buy additional shares of the companies discussed in this opinion and may profit in the event those shares rise in value. When MP receives free trading shares as compensation for a profiled company, MP may sell part or all of any such shares during the period in which MP is performing such services. Market-Pulse.com and Market Pulse Breaking News Alert are owned by Market Pulse LLC.

Contact Information